liraglutide
Victoza (liraglutide) is a once-daily GLP-1 receptor agonist injection used to improve blood sugar control in type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes and established heart disease.
Medically reviewed by MedCentralHub Medical Review Board, Licensed Pharmacists & Physicians ·
Quick Reference

Victoza (liraglutide) is a once-daily GLP-1 receptor agonist injection used to improve blood sugar control in type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes and established heart disease.
Victoza (liraglutide) belongs to the GLP-1 Receptor Agonists class of medications. It was first approved by the FDA in 2010. This medication requires a prescription from a licensed healthcare provider.
This is a summary only. Always read the full prescribing information and consult your healthcare provider for personalized medical advice.
Victoza is prescribed for the following conditions. Some uses are FDA-approved indications; others may be evidence-based off-label uses. Consult your healthcare provider for personalized guidance.

The following are general dosing guidelines only. Your actual dose should be determined by your healthcare provider based on your condition, renal/hepatic function, and other medications.
Start 0.6 mg subcutaneously once daily for 1 week, then increase to 1.2 mg; may increase to 1.8 mg once daily if needed for glycemic control.
Available Forms
Available Strengths


Always inform your healthcare provider and pharmacist about ALL medications you take, including prescriptions, OTC medicines, vitamins, and supplements.
Insulin
Combination substantially increases hypoglycemia risk.
Management: Reduce basal insulin dose by 20% at initiation; monitor blood glucose closely.
Sulfonylureas (glyburide, glipizide)
Additive glucose-lowering increases hypoglycemia risk.
Management: Consider 50% sulfonylurea dose reduction; monitor blood glucose.
Other GLP-1 receptor agonists
Liraglutide is a GLP-1 agonist; combining with another GLP-1 agonist duplicates mechanism with no added benefit.
Management: Contraindicated. Use only one GLP-1 agonist.
Oral medications with narrow therapeutic window
Delayed gastric emptying reduces absorption rate and peak plasma concentrations of oral drugs.
Management: Take narrow-index oral drugs ≥1 hour before liraglutide injection; monitor drug efficacy.
Warfarin
Delayed gastric emptying and GI motility changes may alter warfarin absorption and INR.
Management: Monitor INR at initiation and during dose titration.
Alcohol
May worsen nausea/vomiting side effects and exacerbate hypoglycemia risk.
Management: Advise limiting alcohol intake.
Boxed warning: thyroid C-cell tumor risk; contraindicated with MTC history or MEN 2.
Risk of pancreatitis.
Not indicated for type 1 diabetes or diabetic ketoacidosis.

Liraglutide activates GLP-1 receptors, enhancing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying to lower post-meal glucose.
Absorption
Peak 8–12 hours after SC injection
Half-Life
Approximately 13 hours
Metabolism
Endogenous proteolysis
Excretion
Metabolized; minimal intact renal excretion

Many medications pass into breast milk in varying amounts. Before using Victozawhile breastfeeding, discuss the benefits and risks with your healthcare provider or pharmacist — they can weigh your dose, your infant's age, and available lactation safety data to find the safest option for you and your baby.

Refrigerate before first use; after first use store up to 30°C or refrigerated for 30 days.
Victoza (liraglutide) is once daily; Ozempic (semaglutide) is once weekly and generally provides greater A1C and weight reduction. Both are GLP-1 agonists for type 2 diabetes.
Many people lose modest weight on Victoza, though it is approved for diabetes, not weight management. The 3 mg version (Saxenda) is approved specifically for weight loss.
GLP-1 Receptor Agonists alternatives
Compare all GLP-1 Receptor Agonists medications — uses, side effects, and cost differences
Victoza dosage guide
Adult, pediatric, renal, and hepatic dosing for Victoza
Victoza side effects
Complete adverse effect profile including common, serious, and rare reactions
Victoza drug interactions
Full interaction list with severity ratings for Victoza
Diabetes type 2 treatment options
Medications, lifestyle changes, and clinical guidance for Diabetes type 2
Victoza and Insulin interaction
Check the clinical significance of combining Victoza with Insulin
Victoza and Other GLP-1 receptor agonists interaction
Check the clinical significance of combining Victoza with Other GLP-1 receptor agonists
Victoza (liraglutide) is a once-daily injectable GLP-1 receptor agonist used to improve blood sugar control in adults and children aged 10 and older with type 2 diabetes. Beyond glucose control, it is proven to reduce the risk of major cardiovascular events — heart attack, stroke, and cardiovascular death — in adults with type 2 diabetes and established heart disease, which is a key reason clinicians choose it.
Victoza belongs to the GLP-1 Receptor Agonists class of medications. Liraglutide activates GLP-1 receptors, enhancing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying to lower post-meal glucose. Understanding how Victoza works helps explain both its therapeutic benefits and its characteristic side-effect profile, and it is the reason clinicians monitor specific parameters during treatment.
## What Victoza is used for
Victoza is prescribed for Type 2 diabetes mellitus, Cardiovascular risk reduction in type 2 diabetes. Victoza is added when diet, exercise, and often metformin are not enough to reach blood-sugar goals. Its cardiovascular benefit makes it particularly valuable for patients who already have heart disease. It is not insulin and is not used for type 1 diabetes or diabetic ketoacidosis. Your prescriber decides whether Victoza is appropriate based on your diagnosis, other medical conditions, current medications, and treatment goals. Victoza is available by prescription only and has been FDA-authorized since 2010.
## Dosage and administration
Typical adult dosing: Start 0.6 mg subcutaneously once daily for 1 week, then increase to 1.2 mg; may increase to 1.8 mg once daily if needed for glycemic control.
Treatment begins at 0.6 mg once daily for one week — a starter dose meant to reduce nausea, not to control blood sugar — then increases to 1.2 mg, and up to 1.8 mg if needed. It is injected under the skin once daily at any time, independent of meals. Never change your dose or stop Victoza without speaking to your prescriber. Dose adjustments may be needed for older adults, low body weight, kidney or liver impairment, or when Victoza is combined with interacting drugs. Available forms include Subcutaneous injection (prefilled pen), in strengths of 0.6 mg, 1.2 mg, 1.8 mg.
## Side effects
Like all medicines, Victoza can cause side effects, though many people tolerate it well. Common side effects include Nausea, Diarrhea, Vomiting, Decreased appetite, Headache, Injection-site reaction. These are often mild and tend to settle as your body adjusts. Serious side effects that warrant prompt medical attention include Pancreatitis, Thyroid C-cell tumors (boxed warning), Gallbladder disease, Severe hypoglycemia (with insulin/sulfonylureas). Nausea and other gastrointestinal effects are common early on and usually fade. Victoza carries the GLP-1 class boxed warning for thyroid C-cell tumors and is contraindicated with a history of medullary thyroid carcinoma or MEN 2. Pancreatitis is a rare but serious risk; hypoglycemia is uncommon unless Victoza is combined with insulin or a sulfonylurea. Seek emergency care for signs of a severe allergic reaction — hives, swelling of the face or throat, or difficulty breathing.
## Managing common side effects
Many of the common effects of Victoza can be eased with simple self-care while your body adjusts:
If any side effect is severe, does not improve, or interferes with daily life, contact your healthcare provider rather than stopping Victoza on your own.
## Warnings and precautions
Before starting Victoza, tell your healthcare provider about all your medical conditions and every medication, supplement, and herbal product you take. Key precautions: Boxed warning: thyroid C-cell tumor risk; contraindicated with MTC history or MEN 2; Risk of pancreatitis; Not indicated for type 1 diabetes or diabetic ketoacidosis. Victoza is not suitable for everyone, and certain conditions make it unsafe. During pregnancy, Victoza carries a labeled status of "Not recommended"; discuss the risks and benefits with your clinician if you are pregnant, planning pregnancy, or breastfeeding.
## Drug interactions
Victoza can interact with Insulin and sulfonylureas (moderate) — Increased hypoglycemia risk; Oral medications (minor) — Delayed gastric emptying may alter absorption. Interactions are an important reason to keep your care team informed of every product you use. Because interactions can reduce effectiveness or raise the risk of harm, keep an up-to-date medication list and have your pharmacist run an interaction check whenever a new drug is added.
## Cost, coverage, and savings
Out-of-pocket cost for Victoza varies widely depending on insurance, pharmacy, and whether a generic is available. As a brand-name injectable, Victoza can be costly without good coverage. Manufacturer savings cards and patient-assistance options exist for eligible patients, and many people search for the lowest-cost pharmacy or a Victoza coupon. Patients commonly look for a victoza copay card, manufacturer savings card, or patient assistance program to lower cost; the manufacturer's official site and your pharmacist are the most reliable sources for current offers. Comparing cash prices across pharmacies and discount programs can also produce meaningful savings.
## How Victoza compares to alternatives
Victoza is once daily, while Ozempic and Trulicity are once-weekly GLP-1 options that generally provide somewhat greater A1C and weight reduction. Victoza shares its active ingredient with the weight-loss drug Saxenda but at a lower maximum dose. The "best" option is individual: it depends on your condition, response, tolerability, other medicines, insurance coverage, and dosing convenience. Discuss alternatives with your prescriber rather than switching on your own, and never stop a prescribed medicine abruptly unless told to.
## Monitoring and lifestyle
Treatment with Victoza works best alongside follow-up and healthy habits. Clinicians monitor A1C, weight, and kidney function, and review for any signs of pancreatitis or thyroid symptoms. A balanced diet, regular physical activity appropriate to your health, adequate sleep, limited alcohol, and not smoking all support better outcomes and may improve how well Victoza works. Keep scheduled appointments and laboratory tests so your clinician can confirm the medicine is helping and catch any problems early.
## What to expect from treatment
Knowing the timeline helps set realistic expectations. Victoza is typically absorbed with peak 8–12 hours after sc injection, and has an elimination half-life of about 13 hours, which shapes how often you dose it and how quickly it leaves your system if stopped. Blood-sugar improvements typically begin within the first week or two and continue to build over the following weeks as the dose is increased to its target. Success is measured against your personal treatment goals — whether that is better disease control, fewer symptoms, or reduced long-term risk — so keep your follow-up appointments so progress can be confirmed objectively rather than by guesswork.
## Before you start Victoza
A thorough pre-treatment review helps Victoza work safely. Tell your prescriber about heart, liver, or kidney problems, any history of allergic reactions, and whether you are pregnant or breastfeeding. Bring a complete list of prescription drugs, over-the-counter products, vitamins, and herbal supplements so interactions can be screened. Your clinician will confirm the diagnosis of type 2 diabetes, review your thyroid and pancreatitis history, check kidney function, and teach proper injection technique and safe pen storage before you begin. Ask what results to expect, how long until the medicine takes effect, and which symptoms should prompt a call.
## Missed dose and overdose
If you miss a dose of Victoza, take it as soon as you remember unless it is almost time for the next dose — in that case skip the missed dose and continue your regular schedule. Do not double up to make up for a missed dose. If you suspect an overdose or someone has taken too much, contact your local poison control center or emergency services immediately. Using a pill organizer, phone reminder, or refill-reminder service helps maintain consistent dosing, which is important for Victoza to work properly.
## Use in specific populations
Pregnancy and breastfeeding: Victoza carries a labeled status of "Not recommended." Tell your clinician if you are pregnant, may become pregnant, or are breastfeeding so the safest plan can be chosen. Older adults may be more sensitive to side effects and sometimes need lower doses or closer monitoring. Kidney or liver impairment can change how Victoza is handled by the body and may require dose adjustment. Children and adolescents should use Victoza only when specifically indicated and supervised by an appropriate specialist. Victoza is approved down to age 10 for type 2 diabetes, an important option for younger patients; older adults and those with kidney concerns are watched more closely for dehydration from gastrointestinal side effects.
## When to contact your doctor
Contact your healthcare provider if your symptoms do not improve, if side effects are persistent or troubling, or if you have new symptoms after starting Victoza. Call emergency services for chest pain, trouble breathing, fainting, severe bleeding, sudden severe headache, or signs of a serious allergic reaction. Do not stop Victoza on your own — abrupt discontinuation of some medicines can cause rebound effects or loss of disease control.
## Storage and handling
Refrigerate before first use; after first use store up to 30°C or refrigerated for 30 days. Keep Victoza in its original container, out of the reach of children and pets, and away from excess heat and moisture. Check the expiration date before use and do not use a product that looks discolored or damaged. Dispose of unused or expired medicine safely through a pharmacy take-back program rather than flushing it, unless the label specifically instructs otherwise.
## Clinical evidence and effectiveness
The LEADER trial demonstrated that liraglutide reduced cardiovascular events and death in high-risk type 2 diabetes, establishing its role beyond glucose lowering. The degree of benefit varies from person to person, and real-world results depend on consistent use, adherence to the rest of your treatment plan, and individual factors such as other conditions and medications. Ongoing post-marketing surveillance continues to refine what is known about Victoza's long-term safety and effectiveness, and clinical guidelines are updated as new evidence emerges. Your prescriber can explain what the evidence means for your specific situation and what improvement is realistic to expect.
## Tips for getting the most from Victoza
Consistency is the single most important factor: take Victoza at the same time and in the same way each day, and refill before you run out to avoid interruptions. Keep a simple symptom-and-side-effect diary for the first weeks so you and your clinician can judge how well it is working. Store the medicine correctly, never share it with others, and bring it (or a current list) to every medical appointment. If cost or access is a barrier, raise it early — pharmacists can often suggest generics, manufacturer programs, or therapeutic alternatives that keep you on track.
## Frequently asked questions about Victoza
Victoza (liraglutide) is once daily; Ozempic (semaglutide) is once weekly and generally provides greater A1C and weight reduction. Both are GLP-1 agonists for type 2 diabetes.
Many people lose modest weight on Victoza, though it is approved for diabetes, not weight management. The 3 mg version (Saxenda) is approved specifically for weight loss.
## Key takeaways
To summarize the most important points about Victoza (liraglutide):
## Medical disclaimer
This article about Victoza (liraglutide) is for general education and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the guidance of your physician or pharmacist and the instructions on your prescription label. Information may change as new evidence emerges.
Last reviewed by MedCentralHub Medical Review Board · MedCentralHub Editorial Policy
Medical Disclaimer
The information on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your doctor, pharmacist, or qualified healthcare provider before starting, stopping, or changing any medication.